4-chloro-2-(2-imidazolin-2-ylamino)isoindoline has been researched along with 2-(2-fluoro-5-methylphenyl)-4,5-dihydro-1h-imidazole in 1 studies
| Studies (4-chloro-2-(2-imidazolin-2-ylamino)isoindoline) | Trials (4-chloro-2-(2-imidazolin-2-ylamino)isoindoline) | Recent Studies (post-2010) (4-chloro-2-(2-imidazolin-2-ylamino)isoindoline) | Studies (2-(2-fluoro-5-methylphenyl)-4,5-dihydro-1h-imidazole) | Trials (2-(2-fluoro-5-methylphenyl)-4,5-dihydro-1h-imidazole) | Recent Studies (post-2010) (2-(2-fluoro-5-methylphenyl)-4,5-dihydro-1h-imidazole) |
|---|---|---|---|---|---|
| 12 | 0 | 1 | 5 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agbaba, D; Azzali, E; Costantino, G; Glisic, S; Laurila, JM; Nikolic, K; Perovic, V; Pieroni, M; Radi, M; Scheinin, M; Srdic-Rajic, T; Tassini, S; Veljkovic, N; Vucicevic, J | 1 |
1 other study(ies) available for 4-chloro-2-(2-imidazolin-2-ylamino)isoindoline and 2-(2-fluoro-5-methylphenyl)-4,5-dihydro-1h-imidazole
| Article | Year |
|---|---|
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin.
Topics: Adrenergic alpha-Agonists; Antibiotics, Antineoplastic; Apoptosis; Doxorubicin; Drug Synergism; Humans; K562 Cells; Ligands; Molecular Structure; Oxazoles; Receptors, Adrenergic, alpha-2; Rilmenidine | 2016 |